Would-be Affliction headliner Josh Barnett’s “B” sample also positive for anabolic steroid

Josh Barnett, the would-be “Affliction: Trilogy” headliner who was denied a license for the fight because of a failed drug test, wasn’t cleared of any wrongdoing by his “B” sample.

In an email to MMAjunkie.com, a California State Athletic Commission representative confirmed the sample tested positive for a metabolite of the anabolic steroid Drostanolone.

The initial sample, which forced Barnett out of a scheduled and hugely anticipated Aug. 1 bout with Fedor Emelianenko, detected the same drug.

Related posts:

1. CSAC: Affliction’s Josh Barnett tested positive for anabolic steroid, license denied
2. Josh Barnett Talks Upcoming Fight, Fedor and Steroid Appeal
3. Josh Barnett out of Fedor Emelianenko fight
4. “Affliction: Trilogy” Fedor Emelianenko vs. Josh Barnett headliner could be scrapped
5. Josh Barnett was unaware of random drug testing